DURHAM, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissues at ...
Innovative private equity strategy receives strong reception leading to Forge II expansion REDWOOD CITY, Calif., November 19, 2025--(BUSINESS WIRE)--BVP Forge, a private equity firm for ...
- Positive results from ongoing preclinical studies support the potential of the BVP to deliver insulin-producing islets as a potential treatment for type 1 diabetes - Approximately 1.45 million ...
Innovative private equity strategy receives strong reception leading to Forge II expansion BVP Forge, a private equity firm for growth-oriented, self-sustaining businesses integrated with the assets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results